forbes.com
May 9, 2008
Shares in the drug maker fall after a new threat to its blood-thinning blockbuster Plavix, from a Swiss manufacturer, appears on the horizon. ... LONDON - Europe is not a traditional venue for patent battles in the pharmaceutical industry, but that is precisely where...
[read full story]